biotechnology sector

Massachusetts Governor Maura Healey has approved $40 million in tax incentives for a life science company, a package state officials say will support the creation of 1,600 jobs. The award is part of the state's ongoing effort to keep and grow its biotechnology and life sciences sector, one of Massachusetts' key industries. Details on the company's identity and expansion site were included in the announcement.

China's growing biotechnology companies are presenting themselves to international investors and partners from Shanghai's Zhangjiang district, known as the city's 'Science City.' Reports from STAT and The Boston Globe highlight how these ascendant firms are showcasing drug development capabilities and seeking global recognition as China's life sciences sector expands its international ambitions.

A new analysis outlines the main obstacles Europe's biotechnology industry must overcome to keep growing, including regulatory complexity, difficulty accessing scale-up funding, and competition from the United States and Asia. Commentators argue that without reform of approval processes and better late-stage capital, promising European research and startups will continue to move abroad rather than mature within the EU.

ETF Trends is hosting a webcast titled 'Accessing the peptide economy', examining how investors can gain exposure to companies involved in peptide-based drugs and related biotechnology. The session is expected to cover market opportunities, thematic exchange-traded funds and the growing commercial role of peptide therapeutics in healthcare investing.

A new market research report offers insights into the biological computing industry, outlining expected growth, key market segments and the major competitors active in the field. Biological computing, which uses biological materials such as DNA or living cells to perform computations, is attracting attention as a potential frontier technology, and the report aims to guide investors and companies assessing opportunities in the sector.

Insilico Medicine Cayman TopCo, the Hong Kong-listed biotechnology company trading under ticker 3696.HK, is drawing attention from investors following its listing on the Hong Kong Stock Exchange. The AI-driven drug discovery firm's stock price, quote and trading history are being tracked on financial platforms as markets assess the company's valuation and prospects in the medicine sector.

BioTechniques has published its roundup of biotechnology developments for the end of the third quarter of 2026. The update collects recent news from the sector, covering research tools, laboratory techniques and industry developments. The publication offers a periodic snapshot for scientists and industry watchers tracking where the field stands heading into the final quarter of the year.

A newly formed biotech alliance is calling on Congress to take action to secure American leadership in biotechnology. Writing in Endpoints News, the group argues the US must fight to maintain its dominance in the sector, framing biotech competitiveness as a matter of national policy that lawmakers should prioritize.